ClinicalTrials.Veeva

Menu

Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study (MiCaP)

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Prostate Carcinoma

Treatments

Other: Survey Administration
Other: Media Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05895279
21-006715
NCI-2022-09906 (Registry Identifier)
MiCaP (Other Identifier)

Details and patient eligibility

About

This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Full description

PRIMARY OBJECTIVE:

I. To develop a research dissemination program, the Minority Prostate Cancer (MiCaP) Research Digest, which will spread information about CaP scientific discoveries, evidence-based interventions, and open clinical trials instantly among black males (BM).

OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial.

ARM II: Participants watch an alternative video on study. Participants complete a survey throughout the trial.

Enrollment

220 patients

Sex

Male

Ages

35 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Identify as a Black male
  • Between the ages of 35 and 70
  • For virtual data collection, have access to the internet and Zoom (if joining study online)
  • For virtual data collection, reside anywhere in the U.S.
  • For in-person data collection, reside in one of the nine (9) catchment areas of the Mayo Clinic Cancer Center: Baker, Duval, Nassau, Clay, St. John's, Putnam, Flagler, Volusia and Brevard

Exclusion criteria

  • Identify as a race or ethnicity that is not Black
  • Identify as female
  • Be younger than age 35 and older than age 70
  • Lack access to internet and Zoom (if joining study online)

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

220 participants in 2 patient groups

MiCaP Research Digest Video Group
Experimental group
Description:
Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial.
Treatment:
Other: Media Intervention
Other: Media Intervention
Other: Survey Administration
Alternate Video Group
Active Comparator group
Description:
Participants watch an alternative video on study. Participants complete a survey throughout the trial.
Treatment:
Other: Media Intervention
Other: Media Intervention
Other: Survey Administration

Trial contacts and locations

1

Loading...

Central trial contact

Clinical Trials Referral Office

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems